Market Trends– category –
-
Academic Point-of-Care Manufacturing Offers Cost-Effective CAR-T Access in Low- and Middle-Income Countries
PubMed Global Overview CAR-T cell therapy implementation in Low- and Middle-Income Countries (LMICs) faces significant hurdles due to insufficient infrastructure, complex regulations, and high costs. However, this review suggests that ad... -
GEA Expands Biotech Scale-Up with New $4.7M Sarstedt Technology Center for Precision Fermentation & Cell Cultivation
PPTI News Germany Overview GEA has opened a new US$4.7 million biotech Application and Technology Center in Sarstedt, Germany, dedicated to expanding capabilities in precision fermentation, cell cultivation, and industrial process scale-... -
Market Report: US Autologous CAR-T Cell Therapy Process Optimization Market Driven by Efficiency & Cost Reduction Needs
Intel Market Research USA Overview This article summarizes the "United States Autologous CART Cell Therapy Process Optimization Market Outlook 2026-2034" report. The US autologous CAR-T cell therapy process optimization market is driven ... -
CDMO Signal Ranks Top FDA & GMP-Compliant Lentiviral Vector Manufacturing CDMOs
CDMO Signal Global Overview CDMO Signal has released a ranking of top Lentiviral Vector (LVV) CDMOs, crucial for ex vivo gene therapy, based on FDA inspection history, GMP certification, clinical program activity, and capacity. LVVs are ... -
Real-Time Fermentation Monitoring Achieved with Raman Spectroscopy-Based PAT in Food, Beverage & Industrial Bioprocessing
Technology Networks Global Overview Process Analytical Technology (PAT) tools, particularly Raman and Near-Infrared (NIR) spectroscopy, are extending their application from biopharma bioreactors to industrial fermentation for real-time m... -
CDMO Strategies Advance Next-Gen Biopharma: Automated Closed Systems Tackle Manufacturing Shortages
World Pharma Today Global Overview Contract Development and Manufacturing Organizations (CDMO) strategies are evolving towards end-to-end service models to support the surge in next-generation biopharmaceuticals, especially cell and gene... -
European Biotechs Unveil Next-Gen CGT Manufacturing to Cut CAR-T Costs Above €60,000 Per Patient
PharmTech Global Overview European biopharmaceutical companies are spearheading the development of advanced manufacturing technologies to address the high costs and logistical hurdles of Cell and Gene Therapies (CGT). Innovations include... -
FuelCell Energy Secures $49 Million EXIM Loan to Boost US Clean Energy Exports
GlobeNewswire (via FuelCell Energy's press releases) USA Overview FuelCell Energy, Inc. has secured a $49 million loan from the U.S. Export-Import Bank (EXIM), designated to promote the export of its American-made clean energy solutions ... -
Plug Power Reports Strong Q1 2026 Earnings, Exceeding Revenue Expectations with $163.51M and Improved EPS of -$0.08
MarketBeat USA Overview Plug Power, a leading provider of hydrogen fuel cell solutions, reported robust first-quarter 2026 results on May 11, achieving revenue of $163.51 million, a 22.3% increase year-over-year and surpassing analyst ex... -
Brookfield and Bloom Energy Expand AI Power Partnership to $25 Billion, Boosting On-Site SOFC Generation for Data Centers
Bloom Energy Press Releases USA Overview Brookfield Asset Management has quintupled its partnership with fuel cell manufacturer Bloom Energy, expanding the funding framework from $5 billion to an unprecedented $25 billion. This massive i...
